Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Clinical trial NCT00003327 · UNKNOWN

Trial details

NCT number: NCT00003327
Sponsor: Theradex
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 1997-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.